These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23494875)

  • 1. The role of the CXCR4 cell surface chemokine receptor in glioma biology.
    Ehtesham M; Min E; Issar NM; Kasl RA; Khan IS; Thompson RC
    J Neurooncol; 2013 Jun; 113(2):153-62. PubMed ID: 23494875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arg kinase mediates CXCL12/CXCR4-induced invadopodia formation and invasion of glioma cells.
    Chen L; Zhu M; Yu S; Hai L; Zhang L; Zhang C; Zhao P; Zhou H; Wang S; Yang X
    Exp Cell Res; 2020 Apr; 389(1):111893. PubMed ID: 32035133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CXCR4 in highly malignant human gliomas biology: current knowledge and future directions.
    Gagliardi F; Narayanan A; Reni M; Franzin A; Mazza E; Boari N; Bailo M; Zordan P; Mortini P
    Glia; 2014 Jul; 62(7):1015-23. PubMed ID: 24715652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXCL12/CXCR4 promotes motility and proliferation of glioma cells.
    do Carmo A; Patricio I; Cruz MT; Carvalheiro H; Oliveira CR; Lopes MC
    Cancer Biol Ther; 2010 Jan; 9(1):56-65. PubMed ID: 19923906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the new CXCL12 receptor, CXCR7, in gliomas.
    Calatozzolo C; Canazza A; Pollo B; Di Pierro E; Ciusani E; Maderna E; Salce E; Sponza V; Frigerio S; Di Meco F; Schinelli S; Salmaggi A
    Cancer Biol Ther; 2011 Jan; 11(2):242-53. PubMed ID: 21084856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection.
    Tang W; Wang X; Chen Y; Zhang J; Chen Y; Lin Z
    Pathol Biol (Paris); 2015 Sep; 63(4-5):190-8. PubMed ID: 26277915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4-transfected human umbilical cord blood-derived mesenchymal stem cells exhibit enhanced migratory capacity toward gliomas.
    Park SA; Ryu CH; Kim SM; Lim JY; Park SI; Jeong CH; Jun JA; Oh JH; Park SH; Oh W; Jeun SS
    Int J Oncol; 2011 Jan; 38(1):97-103. PubMed ID: 21109930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CXCL12/CXCR4 signaling in malignant brain tumors: a potential pharmacological therapeutic target.
    Terasaki M; Sugita Y; Arakawa F; Okada Y; Ohshima K; Shigemori M
    Brain Tumor Pathol; 2011 Apr; 28(2):89-97. PubMed ID: 21210239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism.
    Munson JM; Bellamkonda RV; Swartz MA
    Cancer Res; 2013 Mar; 73(5):1536-46. PubMed ID: 23271726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemokine CXC receptor 4--mediated glioma tumor tracking by bone marrow--derived neural progenitor/stem cells.
    Xu Q; Yuan X; Xu M; McLafferty F; Hu J; Lee BS; Liu G; Zeng Z; Black KL; Yu JS
    Mol Cancer Ther; 2009 Sep; 8(9):2746-53. PubMed ID: 19723878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential expression of chemokine receptor CXCR4 by highly malignant human gliomas and its association with poor patient survival.
    Bian XW; Yang SX; Chen JH; Ping YF; Zhou XD; Wang QL; Jiang XF; Gong W; Xiao HL; Du LL; Chen ZQ; Zhao W; Shi JQ; Wang JM
    Neurosurgery; 2007 Sep; 61(3):570-8; discussion 578-9. PubMed ID: 17881971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An infernal trio: the chemokine CXCL12 and its receptors CXCR4 and CXCR7 in tumor biology.
    Hattermann K; Mentlein R
    Ann Anat; 2013 Mar; 195(2):103-10. PubMed ID: 23279723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetramethylpyrazine (TMP) protects cerebral neurocytes and inhibits glioma by down regulating chemokine receptor CXCR4 expression.
    Chen Z; Pan X; Georgakilas AG; Chen P; Hu H; Yang Y; Tian S; Xia L; Zhang J; Cai X; Ge J; Yu K; Zhuang J
    Cancer Lett; 2013 Aug; 336(2):281-9. PubMed ID: 23523616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CXCR4-positive subset of glioma is enriched for cancer stem cells.
    Zheng X; Xie Q; Li S; Zhang W
    Oncol Res; 2011; 19(12):555-61. PubMed ID: 22812188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 expression mediates glioma cell invasiveness.
    Ehtesham M; Winston JA; Kabos P; Thompson RC
    Oncogene; 2006 May; 25(19):2801-6. PubMed ID: 16407848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular host responses to gliomas.
    Najbauer J; Huszthy PC; Barish ME; Garcia E; Metz MZ; Myers SM; Gutova M; Frank RT; Miletic H; Kendall SE; Glackin CA; Bjerkvig R; Aboody KS
    PLoS One; 2012; 7(4):e35150. PubMed ID: 22539956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells.
    Razmkhah M; Arabpour F; Taghipour M; Mehrafshan A; Chenari N; Ghaderi A
    Asian Pac J Cancer Prev; 2014; 15(17):7201-5. PubMed ID: 25227814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.